Skip to main content

Highlights

  1. 1
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2023
    PMID: 36745977DOISenior author

Publications

20 publications

Funding

1 grant
Completed grants (1)
  • Sub-PI
    Bacterial Characteristics of Community-associated Carbapenem-Resistant Enterobacteriaceae
    National Institute of Allergy and Infectious Diseases · 2020–2024 · via University of North Carolina at Chapel Hill
    R01AI143910-04

Clinical research

6 studies

Active

3 studies
  • PI
    SPIND 183922 Clofazimine
    Novartis Pharmaceuticals Corporation · OPEN TO ACCRUAL (as of 2026)
  • PI
    SPIND 180201 Clofazimine
    Novartis Pharmaceuticals Corporation · OPEN TO ACCRUAL (as of 2025)
  • PI
    A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
    PHASE3 · Ansun BioPharma, Inc. · OPEN TO ACCRUAL (as of 2020)
    Lower Respiratory Tract Infection; Parainfluenza; Immunocompromised; COVID-19
    NCT03808922
Completed & closed trials (3)
  • PI
    SPIND 175628 Clofazimine
    Novartis Pharmaceuticals Corporation · CLOSED TO ACCRUAL (as of 2025)
  • PI
    Community-associated Highly-Resistant Enterobacterales
    University of North Carolina · IRB STUDY CLOSURE (as of 2023)
    Enterobacteriaceae Infections; Community-Acquired Infections; Healthcare Associated Infection; Carbapenem-Resistant Enterobacteriaceae Infection
    NCT03924934
  • PI
    Emergency Use of Cefiderocol
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2020)